UNICA IRIS Institutional Research Information System

MASSA, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 106.928
NA - Nord America 8.519
AS - Asia 960
SA - Sud America 17
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 116.444
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 104.568
US - Stati Uniti d'America 8.471
UA - Ucraina 952
CN - Cina 809
SE - Svezia 579
GB - Regno Unito 226
FI - Finlandia 225
DE - Germania 192
FR - Francia 75
SG - Singapore 53
CA - Canada 44
IN - India 33
NL - Olanda 22
BE - Belgio 20
IR - Iran 17
IE - Irlanda 14
RU - Federazione Russa 13
VN - Vietnam 12
BR - Brasile 10
ES - Italia 10
CZ - Repubblica Ceca 8
KR - Corea 8
EU - Europa 7
TW - Taiwan 7
AT - Austria 6
HK - Hong Kong 5
AU - Australia 4
JP - Giappone 4
MX - Messico 4
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
TR - Turchia 3
UG - Uganda 3
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
EG - Egitto 2
ID - Indonesia 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
AM - Armenia 1
AR - Argentina 1
CO - Colombia 1
EC - Ecuador 1
HU - Ungheria 1
IL - Israele 1
MU - Mauritius 1
NG - Nigeria 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 116.444
Salva come PNG Salva come JPEG
Città #
Cagliari 104.005
Fairfield 1.171
Woodbridge 1.023
Houston 822
Chandler 678
Ashburn 568
Jacksonville 555
Seattle 495
Wilmington 483
Ann Arbor 480
Nyköping 468
Cambridge 413
Dearborn 257
Boardman 171
Nanjing 171
Boston 132
Beijing 121
New York 95
San Diego 92
Helsinki 83
Shanghai 63
Guangzhou 62
Milan 58
Nanchang 56
Shenyang 45
Hebei 42
Redwood City 36
Changsha 34
Verona 32
Toronto 31
Jiaxing 29
Norwalk 28
Rome 27
Tianjin 27
London 26
Orange 26
Jinan 24
Pune 20
Auburn Hills 19
Sassari 19
Brussels 18
Mountain View 18
Kunming 17
Hangzhou 15
Zhengzhou 15
Dublin 14
Hefei 14
Singapore 14
San Mateo 13
Amsterdam 12
Dong Ket 12
Los Angeles 12
Ningbo 12
Kilburn 10
Taizhou 9
Augusta 8
Kyjov 8
Rio de Janeiro 8
Hounslow 7
Torino 7
Atlanta 6
Chicago 6
Leawood 6
Paris 6
Phoenix 6
Redmond 6
Saint Petersburg 6
San Sperate 6
Turin 6
Vienna 6
Washington 6
Wuhan 6
Barcelona 5
Borås 5
Brandizzo 5
Monmouth Junction 5
Salerno 5
Xian 5
Halle 4
Indiana 4
Mexico City 4
Millbury 4
Mumbai 4
Rockville 4
Sheffield 4
Somma Vesuviana 4
Taipei 4
Amman 3
Ardabil 3
Baltimore 3
Copenhagen 3
Fuzhou 3
Islington 3
Kampala 3
Manchester 3
Nanning 3
Nuoro 3
Quartu Sant'Elena 3
San Francisco 3
Ussana 3
Totale 113.407
Salva come PNG Salva come JPEG
Nome #
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.647
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.549
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.326
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 2.236
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.232
Sense of coherence and physical health-related quality of life in Italian chronic patients: The mediating role of the mental component 2.228
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.136
Molecular-biology-driven treatment for metastatic colorectal cancer 2.068
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 1.987
Health related quality of life in patients with onco-hematological diseases 1.863
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 1.786
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.707
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial 1.615
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.549
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 1.514
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.512
null 1.489
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.489
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial 1.484
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.476
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.461
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.438
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 1.431
Case-control Phase ii clinical trial to assess efficacy and safety, of the same antineoplastic treatment(s) in elderly "fit" compared to adult patients with cancer at different sites 1.341
Weight loss in cancer patients: a plea for a better awareness of the issue 1.300
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause 1.294
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.294
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up 1.291
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 1.284
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia = Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: Final analysis of GIDEON study in Italy 1.257
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.196
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.121
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.076
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.026
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 981
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship? 963
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma 949
null 944
Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens 909
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 835
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 782
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 773
null 768
An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study 763
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 755
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 751
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 717
null 709
null 694
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 683
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 681
null 681
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. 680
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 664
Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients 660
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 649
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 646
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 630
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 629
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 621
Moderate exercise improves cognitive function in healthy elderly people: results of a randomized controlled trial 621
PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the Literature 620
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 615
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 602
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 601
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 573
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 573
null 572
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 569
Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy 569
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 563
Early epirubicin (EPI)-induced myocardial dysfunction revealed by serial tissue doppler imaging (TDI): Correlation with inflammatory and oxidative stress markers 523
Managing cancer-related anorexia/cachexia 506
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 503
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 487
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 485
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 475
null 465
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 462
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 462
Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer 460
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 453
null 450
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 448
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 445
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 443
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 438
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 436
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 434
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 433
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 425
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 420
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 419
Cancer related anorexia/cachexia (CACS) and oxidative stress: an innovative approach beyond current treatment 418
Early contractility impairment during anthracycline treatment revealed by serial tissue Doppler echocardiography in presence of negative biochemical markers 413
null 413
Phase II study with antioxidants, both in the diet and supplemented pharmaco-nutritional support, progestagen and anti-cox-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 409
Assessment of impact on quality of life (QOL) of endoscopic laser ablation (LA) as palliative treatment of endobronchial, non-resectable or recurrent lung cancer 404
Cancer related anorexia/cachexia (CACS) and oxidative stress: an innovative approach beyond current treatment 401
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 400
Totale 94.628
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.122 0 0 0 0 0 0 0 0 0 0 561 561
2019/202024.428 1.531 636 170 555 8.172 6.096 3.205 945 608 518 522 1.470
2020/202135.147 1.139 1.216 1.389 7.968 7.397 4.884 3.622 2.503 803 1.576 1.532 1.118
2021/20226.681 644 561 269 475 662 504 320 348 585 493 814 1.006
2022/202312.130 957 1.396 1.209 1.050 1.060 1.213 578 1.443 834 774 1.020 596
2023/202413.215 1.362 546 512 1.012 1.583 3.200 1.586 1.025 789 1.360 240 0
Totale 116.778